HPV Vaccine: Updates and Highlights

https://doi.org/10.1016/j.semcancer.2013.11.002

2.

Tommasino

M

.

The human papillomavirus family and its role in carcinogenesis

.

Semin Cancer Biol

.

2014

Jun

;

26

:

13

–

21

.

[PubMed]

1044-579X

https://doi.org/10.1128/JVI.00114-11

3.

Accardi

R

,

Rubino

R

,

Scalise

M

,

Gheit

T

,

Shahzad

N

,

Thomas

M

, et al

E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1

.

J Virol

.

2011

Aug

;

85

(

16

):

8208

–

16

.

[PubMed]

0022-538X

https://doi.org/10.1016/j.tim.2010.07.008

4.

Bravo

IG

,

de Sanjosé

S

,

Gottschling

M

.

The clinical importance of understanding the evolution of papillomaviruses

.

Trends Microbiol

.

2010

Oct

;

18

(

10

):

432

–

8

.

[PubMed]

0966-842X

https://doi.org/10.1016/j.jcv.2004.10.021

5.

Bernard

HU

.

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

.

J Clin Virol

.

2005

Mar

;

32

Suppl 1

:

S1

–

6

.

[PubMed]

1386-6532

https://doi.org/10.1016/S1470-2045(09)70096-8

6.

Bouvard

V

,

Baan

R

,

Straif

K

,

Grosse

Y

,

Secretan

B

,

El Ghissassi

F

, et al;

WHO International Agency for Research on Cancer Monograph Working Group

.

A review of human carcinogens—Part B: biological agents

.

Lancet Oncol

.

2009

Apr

;

10

(

4

):

321

–

2

.

[PubMed]

1470-2045

https://doi.org/10.3390/ijerph15102210

7.

Rodríguez-Álvarez

MI

,

Gómez-Urquiza

JL

,

Husein-El Ahmed

H

,

Albendín-García

L

,

Gómez-Salgado

J

,

Cañadas-De la Fuente

GA

.

Prevalence and Risk Factors of Human Papillomavirus in Male Patients: A Systematic Review and Meta-Analysis

.

Int J Environ Res Public Health

.

2018

Oct

;

15

(

10

):

E2210

.

[PubMed]

1661-7827

https://doi.org/10.1086/657321

8.

Bruni

L

,

Diaz

M

,

Castellsagué

X

,

Ferrer

E

,

Bosch

FX

,

de Sanjosé

S

.

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings

.

J Infect Dis

.

2010

Dec

;

202

(

12

):

1789

–

99

.

[PubMed]

0022-1899

https://doi.org/10.1016/j.ajog.2015.03.034

9.

Stier

EA

,

Sebring

MC

,

Mendez

AE

,

Ba

FS

,

Trimble

DD

,

Chiao

EY

.

Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review

.

Am J Obstet Gynecol

.

2015

Sep

;

213

(

3

):

278

–

309

.

[PubMed]

0002-9378

https://doi.org/10.1038/nrdp.2016.86

10.

Schiffman

M

,

Doorbar

J

,

Wentzensen

N

,

de Sanjosé

S

,

Fakhry

C

,

Monk

BJ

, et al

Carcinogenic human papillomavirus infection

.

Nat Rev Dis Primers

.

2016

Dec

;

2

:

16086

.

[PubMed]

2056-676X

https://doi.org/10.1016/S0140-6736(07)61416-0

11.

Schiffman

M

,

Castle

PE

,

Jeronimo

J

,

Rodriguez

AC

,

Wacholder

S

.

Human papillomavirus and cervical cancer

.

Lancet

.

2007

Sep

;

370

(

9590

):

890

–

907

.

[PubMed]

0140-6736

https://doi.org/10.1128/JCM.41.6.2509-2514.2003

12.

Antonsson

A

,

Karanfilovska

S

,

Lindqvist

PG

,

Hansson

BG

.

General acquisition of human papillomavirus infections of skin occurs in early infancy

.

J Clin Microbiol

.

2003

Jun

;

41

(

6

):

2509

–

14

.

[PubMed]

0095-1137

https://doi.org/10.1016/j.virol.2013.06.007

13.

Cubie

HA

.

Diseases associated with human papillomavirus infection

.

Virology

.

2013

Oct

;

445

(

1-2

):

21

–

34

.

[PubMed]

0042-6822

https://doi.org/10.3322/caac.21492

14.

Bray

F

,

Ferlay

J

,

Soerjomataram

I

,

Siegel

RL

,

Torre

LA

,

Jemal

A

.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

.

CA Cancer J Clin

.

2018

Nov

;

68

(

6

):

394

–

424

.

[PubMed]

0007-9235

https://doi.org/10.1136/jcp.55.4.244

15.

Bosch

FX

,

Lorincz

A

,

Muñoz

N

,

Meijer

CJ

,

Shah

KV

.

The causal relation between human papillomavirus and cervical cancer

.

J Clin Pathol

.

2002

Apr

;

55

(

4

):

244

–

65

.

[PubMed]

0021-9746

https://doi.org/10.1016/S1470-2045(10)70230-8

16.

de Sanjose

S

,

Quint

WG

,

Alemany

L

,

Geraets

DT

,

Klaustermeier

JE

,

Lloveras

B

, et al;

Retrospective International Survey and HPV Time Trends Study Group

.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

.

Lancet Oncol

.

2010

Nov

;

11

(

11

):

1048

–

56

.

[PubMed]

1470-2045

https://doi.org/10.1002/ijc.24116

17.

De Vuyst

H

,

Clifford

GM

,

Nascimento

MC

,

Madeleine

MM

,

Franceschi

S

.

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

.

Int J Cancer

.

2009

Apr

;

124

(

7

):

1626

–

36

.

[PubMed]

0020-7136

https://doi.org/10.1002/ijc.28963

18.

Alemany

L

,

Saunier

M

,

Alvarado-Cabrero

I

,

Quirós

B

,

Salmeron

J

,

Shin

HR

, et al;

HPV VVAP Study Group

.

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

.

Int J Cancer

.

2015

Jan

;

136

(

1

):

98

–

107

.

[PubMed]

0020-7136

https://doi.org/10.1136/jcp.2008.063149

19.

Miralles-Guri

C

,

Bruni

L

,

Cubilla

AL

,

Castellsagué

X

,

Bosch

FX

,

de Sanjosé

S

.

Human papillomavirus prevalence and type distribution in penile carcinoma

.

J Clin Pathol

.

2009

Oct

;

62

(

10

):

870

–

8

.

[PubMed]

0021-9746

https://doi.org/10.3322/caac.21384

20.

Shield

KD

,

Ferlay

J

,

Jemal

A

,

Sankaranarayanan

R

,

Chaturvedi

AK

,

Bray

F

, et al

The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012

.

CA Cancer J Clin

.

2017

Jan

;

67

(

1

):

51

–

64

.

[PubMed]

0007-9235

https://doi.org/10.1016/j.bpobgyn.2017.08.006

21.

Serrano

B

,

Brotons

M

,

Bosch

FX

,

Bruni

L

.

Epidemiology and burden of HPV-related disease

.

Best Pract Res Clin Obstet Gynaecol

.

2018

Feb

;

47

:

14

–

26

.

[PubMed]

1521-6934

22.

Jarrett

WF

,

O’Neil

BW

,

Gaukroger

JM

,

Laird

HM

,

Smith

KT

,

Campo

MS

.

Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination

.

Vet Rec

.

1990

May

;

126

(

18

):

449

–

52

.

[PubMed]

0042-4900

https://doi.org/10.1159/000163910

23.

Bell

JA

,

Sundberg

JP

,

Ghim

SJ

,

Newsome

J

,

Jenson

AB

,

Schlegel

R

.

A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model

.

Pathobiology

.

1994

;

62

(

4

):

194

–

8

.

[PubMed]

1015-2008

https://doi.org/10.4049/jimmunol.1490012

24.

Frazer

IH

.

Development and implementation of papillomavirus prophylactic vaccines

.

J Immunol

.

2014

May

;

192

(

9

):

4007

–

11

.

[PubMed]

0022-1767

25.

Breitburd

F

,

Kirnbauer

R

,

Hubbert

NL

,

Nonnenmacher

B

,

Trin-Dinh-Desmarquet

C

,

Orth

G

, et al

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

.

J Virol

.

1995

Jun

;

69

(

6

):

3959

–

63

.

[PubMed]

0022-538X

https://doi.org/10.1093/jnci/djg018

26.

Nardelli-Haefliger

D

,

Wirthner

D

,

Schiller

JT

,

Lowy

DR

,

Hildesheim

A

,

Ponci

F

, et al

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

.

J Natl Cancer Inst

.

2003

Aug

;

95

(

15

):

1128

–

37

.

[PubMed]

0027-8874

https://doi.org/10.1016/j.vaccine.2004.02.020

27.

Ault

KA

,

Giuliano

AR

,

Edwards

RP

,

Tamms

G

,

Kim

LL

,

Smith

JF

, et al

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

.

Vaccine

.

2004

Aug

;

22

(

23-24

):

3004

–

7

.

[PubMed]

0264-410X

https://doi.org/10.1093/jnci/93.4.284

28.

Harro

CD

,

Pang

YY

,

Roden

RB

,

Hildesheim

A

,

Wang

Z

,

Reynolds

MJ

, et al

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

.

J Natl Cancer Inst

.

2001

Feb

;

93

(

4

):

284

–

92

.

[PubMed]

0027-8874

https://doi.org/10.1016/j.vaccine.2006.06.005

29.

Giannini

SL

,

Hanon

E

,

Moris

P

,

Van Mechelen

M

,

Morel

S

,

Dessy

F

, et al

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

.

Vaccine

.

2006

Aug

;

24

(

33-34

):

5937

–

49

.

[PubMed]

0264-410X

https://doi.org/10.1056/NEJMoa061760

30.

Garland

SM

,

Hernandez-Avila

M

,

Wheeler

CM

,

Perez

G

,

Harper

DM

,

Leodolter

S

, et al;

Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators

.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

.

N Engl J Med

.

2007

May

;

356

(

19

):

1928

–

43

.

[PubMed]

0028-4793

https://doi.org/10.1056/NEJMoa061741

31.

Group

FI

;

FUTURE II Study Group

.

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

.

N Engl J Med

.

2007

May

;

356

(

19

):

1915

–

27

.

[PubMed]

0028-4793

https://doi.org/10.1056/NEJMoa0909537

32.

Giuliano

AR

,

Palefsky

JM

,

Goldstone

S

,

Moreira

ED

Jr,

Penny

ME

,

Aranda

C

, et al

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

.

N Engl J Med

.

2011

Feb

;

364

(

5

):

401

–

11

.

[PubMed]

0028-4793

https://doi.org/10.1016/S0140-6736(07)60946-5

33.

Paavonen

J

,

Jenkins

D

,

Bosch

FX

,

Naud

P

,

Salmerón

J

,

Wheeler

CM

, et al;

HPV PATRICIA study group

.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

.

Lancet

.

2007

Jun

;

369

(

9580

):

2161

–

70

.

[PubMed]

0140-6736

https://doi.org/10.1016/j.vaccine.2014.06.038

34.

Hildesheim

A

,

Wacholder

S

,

Catteau

G

,

Struyf

F

,

Dubin

G

,

Herrero

R

;

CVT Group

.

Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial

.

Vaccine

.

2014

Sep

;

32

(

39

):

5087

–

97

.

[PubMed]

0264-410X

https://doi.org/10.1056/NEJMoa1405044

35.

Joura

EA

,

Giuliano

AR

,

Iversen

OE

,

Bouchard

C

,

Mao

C

,

Mehlsen

J

, et al;

Broad Spectrum HPV Vaccine Study

.

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women

.

N Engl J Med

.

2015

Feb

;

372

(

8

):

711

–

23

.

[PubMed]

0028-4793

https://doi.org/10.1016/S0140-6736(09)61567-1

36.

WHO

.

Human papillomavirus and HPV vaccines: technical information for policy-makers and health professionals

.

Geneve

:

WHO Press

;

2007

.

43

pp.

37.

Romanowski

B

,

de Borba

PC

,

Naud

PS

,

Roteli-Martins

CM

,

De Carvalho

NS

,

Teixeira

JC

, et al;

GlaxoSmithKline Vaccine HPV-007 Study Group

.

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

.

Lancet

.

2009

Dec

;

374

(

9706

):

1975

–

85

.

[PubMed]

0140-6736

https://doi.org/10.1097/INF.0000000000000773

38.

Vesikari

T

,

Brodszki

N

,

van Damme

P

,

Diez-Domingo

J

,

Icardi

G

,

Petersen

LK

, et al

A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls

.

Pediatr Infect Dis J

.

2015

Sep

;

34

(

9

):

992

–

8

.

[PubMed]

0891-3668

https://doi.org/10.1097/01.inf.0000253970.29190.5a

39.

Reisinger

KS

,

Block

SL

,

Lazcano-Ponce

E

,

Samakoses

R

,

Esser

MT

,

Erick

J

, et al

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial

.

Pediatr Infect Dis J

.

2007

Mar

;

26

(

3

):

201

–

9

.

[PubMed]

0891-3668

https://doi.org/10.1016/j.jadohealth.2007.02.015

40.

Pedersen

C

,

Petaja

T

,

Strauss

G

,

Rumke

HC

,

Poder

A

,

Richardus

JH

, et al;

HPV Vaccine Adolescent Study Investigators Network

.

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant

.

J Adolesc Health

.

2007

Jun

;

40

(

6

):

564

–

71

.

[PubMed]

1054-139X

https://doi.org/10.4161/hv.5.10.9518

41.

Einstein

MH

,

Baron

M

,

Levin

MJ

,

Chatterjee

A

,

Edwards

RP

,

Zepp

F

, et al;

HPV-010 Study Group

.

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

.

Hum Vaccin

.

2009

Oct

;

5

(

10

):

705

–

19

.

[PubMed]

1554-8600

https://doi.org/10.1016/j.vaccine.2017.12.078

42.

Kreimer

AR

,

Herrero

R

,

Sampson

JN

,

Porras

C

,

Lowy

DR

,

Schiller

JT

, et al;

Costa Rica HPV Vaccine Trial (CVT) Group

.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies

.

Vaccine

.

2018

Aug

;

36

(

32

32 Pt A

):

4774

–

82

.

[PubMed]

0264-410X

https://doi.org/10.1016/j.vaccine.2018.02.087

43.

Sankaranarayanan

R

,

Joshi

S

,

Muwonge

R

,

Esmy

PO

,

Basu

P

,

Prabhu

P

, et al;

Indian HPV vaccine study group

.

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study

.

Vaccine

.

2018

Aug

;

36

(

32

32 Pt A

):

4783

–

91

.

[PubMed]

0264-410X

https://doi.org/10.1080/14760584.2018.1548282

44.

Arbyn

M

,

Xu

L

.

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials

.

Expert Rev Vaccines

.

2018

Dec

;

17

(

12

):

1085

–

91

.

[PubMed]

1476-0584

https://doi.org/10.1016/S0140-6736(17)31821-4

45.

Huh

WK

,

Joura

EA

,

Giuliano

AR

,

Iversen

OE

,

de Andrade

RP

,

Ault

KA

, et al

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

.

Lancet

.

2017

Nov

;

390

(

10108

):

2143

–

59

.

[PubMed]

0140-6736

https://doi.org/10.1016/S1470-2045(11)70213-3

46.

Palefsky

J

,

Giuliano

A

. Efficacy of quadrivalent HPV vaccine against HVP 6/11/16/18-related genital infection in young men. EUROGIN 2008; Nice, France

2008

.

47.

Kreimer

AR

,

González

P

,

Katki

HA

,

Porras

C

,

Schiffman

M

,

Rodriguez

AC

, et al;

CVT Vaccine Group

.

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

.

Lancet Oncol

.

2011

Sep

;

12

(

9

):

862

–

70

.

[PubMed]

1470-2045

48.

Toh

ZQ

,

Russell

FM

,

Reyburn

R

,

Fong

J

,

Tuivaga

E

,

Ratu

T

, et al

Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study

.

Clin Infect Dis

.

2017

Apr

;

64

(

7

):

852

–

9

.

[PubMed]

1537-6591

https://doi.org/10.1016/S1473-3099(10)70225-5

49.

Donovan

B

,

Franklin

N

,

Guy

R

,

Grulich

AE

,

Regan

DG

,

Ali

H

, et al

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

.

Lancet Infect Dis

.

2011

Jan

;

11

(

1

):

39

–

44

.

[PubMed]

1473-3099

https://doi.org/10.1136/sextrans-2011-050234

50.

Read

TR

,

Hocking

JS

,

Chen

MY

,

Donovan

B

,

Bradshaw

CS

,

Fairley

CK

.

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

.

Sex Transm Infect

.

2011

Dec

;

87

(

7

):

544

–

7

.

[PubMed]

1368-4973

https://doi.org/10.2105/AJPH.2011.300465

51.

Bauer

HM

,

Wright

G

,

Chow

J

.

Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010

.

Am J Public Health

.

2012

May

;

102

(

5

):

833

–

5

.

[PubMed]

0090-0036

https://doi.org/10.1136/sextrans-2016-052626

52.

Canvin

M

,

Sinka

K

,

Hughes

G

,

Mesher

D

.

Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis

.

Sex Transm Infect

.

2017

Mar

;

93

(

2

):

125

–

8

.

[PubMed]

1368-4973

https://doi.org/10.21149/7824

53.

Tejada

RA

,

Vargas

KG

,

Benites-Zapata

V

,

Mezones-Holguín

E

,

Bolaños-Díaz

R

,

Hernandez

AV

.

Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis

.

Salud Publica Mex

.

2017

Jan-Feb

;

59

(

1

):

84

–

94

.

[PubMed]

0036-3634

https://doi.org/10.1016/S0140-6736(11)60551-5

54.

Brotherton

JM

,

Fridman

M

,

May

CL

,

Chappell

G

,

Saville

AM

,

Gertig

DM

.

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

.

Lancet

.

2011

Jun

;

377

(

9783

):

2085

–

92

.

[PubMed]

0140-6736

https://doi.org/10.1002/ijc.29508

55.

Ogilvie

GS

,

Naus

M

,

Money

DM

,

Dobson

SR

,

Miller

D

,

Krajden

M

, et al

Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: an ecological analysis

.

Int J Cancer

.

2015

Oct

;

137

(

8

):

1931

–

7

.

[PubMed]

0020-7136

https://doi.org/10.1002/ijc.30035

56.

Herweijer

E

,

Sundström

K

,

Ploner

A

,

Uhnoo

I

,

Sparén

P

,

Arnheim-Dahlström

L

.

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study

.

Int J Cancer

.

2016

Jun

;

138

(

12

):

2867

–

74

.

[PubMed]

0020-7136

https://doi.org/10.2105/AJPH.2016.303472

57.

Flagg

EW

,

Torrone

EA

,

Weinstock

H

.

Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014

.

Am J Public Health

.

2016

Dec

;

106

(

12

):

2211

–

8

.

[PubMed]

0090-0036

https://doi.org/10.4103/ijpvm.IJPVM_413_16

58.

Haghshenas

MR

,

Mousavi

T

,

Kheradmand

M

,

Afshari

M

,

Moosazadeh

M

.

Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis

.

Int J Prev Med

.

2017

Jun

;

8

(

1

):

44

.

[PubMed]

2008-7802

59.

Bonaldo

G

,

Vaccheri

A

,

D’Annibali

O

,

Motola

D

.

Safety profile of HPV vaccines: an analysis of the USA Vaccine Adverse Event Reporting System (VAERS) from 2007-2017

.

Br J Clin Pharmacol

.

2018

.0306-5251

https://doi.org/10.1016/j.vaccine.2017.07.113

60.

Maver

PJ

,

Poljak

M

.

Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review

.

Vaccine

.

2018

Aug

;

36

(

36

):

5416

–

23

.

[PubMed]

0264-410X

https://doi.org/10.1016/S2214-109X(16)30099-7

61.

Bruni

L

,

Diaz

M

,

Barrionuevo-Rosas

L

,

Herrero

R

,

Bray

F

,

Bosch

FX

, et al

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

.

Lancet Glob Health

.

2016

Jul

;

4

(

7

):

e453

–

63

.

[PubMed]

2214-109X

https://doi.org/10.1177/2150131917742299

62.

Loke

AY

,

Kwan

ML

,

Wong

YT

,

Wong

AK

.

The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review

.

J Prim Care Community Health

.

2017

Oct

;

8

(

4

):

349

–

62

.

[PubMed]

2150-1319

https://doi.org/10.1186/s12913-016-1824-5

63.

Ladner

J

,

Besson

MH

,

Audureau

E

,

Rodrigues

M

,

Saba

J

.

Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014

.

BMC Health Serv Res

.

2016

Oct

;

16

(

1

):

575

.

[PubMed]

1472-6963

https://doi.org/10.1016/j.vaccine.2012.06.075

64.

Kane

MA

,

Serrano

B

,

de Sanjosé

S

,

Wittet

S

.

Implementation of human papillomavirus immunization in the developing world

.

Vaccine

.

2012

Nov

;

30

Suppl 5

:

F192

–

200

.

[PubMed]

0264-410X

https://doi.org/10.1371/journal.pone.0149857

65.

PAHO

.

Pan American Health Organization.

About PAHO Revolving Fund: PAHO;

2017

[Available from: http://www2.paho.org/hq/index.php?option=com_content&view=article&id=9 562&Itemid=40717&lang=pt.

66.

Rehn

M

,

Uhnoo

I

,

Kühlmann-Berenzon

S

,

Wallensten

A

,

Sparén

P

,

Netterlid

E

.

Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden

.

PLoS One

.

2016

Mar

;

11

(

3

):

e0149857

.

[PubMed]

1932-6203

https://doi.org/10.1016/j.vaccine.2014.11.037

67.

Vandelaer

J

,

Olaniran

M

.

Using a school-based approach to deliver immunization—global update

.

Vaccine

.

2015

Jan

;

33

(

5

):

719

–

25

.

[PubMed]

0264-410X

https://doi.org/10.1371/journal.pone.0062647

68.

Fregnani

JH

,

Carvalho

AL

,

Eluf-Neto

J

,

Ribeiro

KC

,

Kuil

LM

,

da Silva

TA

, et al

A school-based human papillomavirus vaccination program in barretos, Brazil: final results of a demonstrative study

.

PLoS One

.

2013

Apr

;

8

(

4

):

e62647

.

[PubMed]

1932-6203

https://doi.org/10.1001/jama.2013.1625

69.

Dobson

SR

,

McNeil

S

,

Dionne

M

,

Dawar

M

,

Ogilvie

G

,

Krajden

M

, et al

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial

.

JAMA

.

2013

May

;

309

(

17

):

1793

–

802

.

[PubMed]

0098-7484

https://doi.org/10.1186/1471-2458-12-370

70.

Ladner

J

,

Besson

MH

,

Hampshire

R

,

Tapert

L

,

Chirenje

M

,

Saba

J

.

Assessment of eight HPV vaccination programs implemented in lowest income countries

.

BMC Public Health

.

2012

May

;

12

(

1

):

370

.

[PubMed]

1471-2458

https://doi.org/10.1016/j.vaccine.2015.01.068

71.

Roberts

JR

,

Thompson

D

,

Rogacki

B

,

Hale

JJ

,

Jacobson

RM

,

Opel

DJ

, et al

Vaccine hesitancy among parents of adolescents and its association with vaccine uptake

.

Vaccine

.

2015

Mar

;

33

(

14

):

1748

–

55

.

[PubMed]

0264-410X

https://doi.org/10.1111/j.1525-1438.2006.00377.x

72.

Moreira

ED

Jr,

Oliveira

BG

,

Ferraz

FM

,

Costa

S

,

Costa Filho

JO

,

Karic

G

.

Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention

.

Int J Gynecol Cancer

.

2006

Mar-Apr

;

16

(

2

):

599

–

603

.

[PubMed]

1048-891X

https://doi.org/10.1371/journal.pone.0206726

73.

Mendes Lobão

W

,

Duarte

FG

,

Burns

JD

,

de Souza Teles Santos

CA

,

Chagas de Almeida

MC

,

Reingold

A

, et al

Low coverage of HPV vaccination in the national immunization programme in Brazil: parental vaccine refusal or barriers in health-service based vaccine delivery?

PLoS One

.

2018

Nov

;

13

(

11

):

e0206726

.

[PubMed]

1932-6203

https://doi.org/10.1016/S0264-410X(00)00469-2

74.

Poland

GA

,

Jacobson

RM

.

Understanding those who do not understand: a brief review of the anti-vaccine movement

.

Vaccine

.

2001

Mar

;

19

(

17-19

):

2440

–

5

.

[PubMed]

0264-410X

https://doi.org/10.7759/cureus.2919

75.

Hussain

A

,

Ali

S

,

Ahmed

M

,

Hussain

S

.

The Anti-vaccination Movement: A Regression in Modern Medicine

.

Cureus

.

2018

Jul

;

10

(

7

):

e2919

.

[PubMed]

2168-8184

https://doi.org/10.1080/21645515.2015.1125055

76.

Smulian

EA

,

Mitchell

KR

,

Stokley

S

.

Interventions to increase HPV vaccination coverage: A systematic review

.

Hum Vaccin Immunother

.

2016

Jun

;

12

(

6

):

1566

–

88

.

[PubMed]

2164-5515

https://doi.org/10.11606/issn.1679-9836.v97i1p81-97

77.

Freitas

AC

,

Gonzalez

AJ

,

Guimarães

G

,

Villa

LL

.

Human papillomavirus vaccination in national immunization programs: impact and perspectives

.

Rev Med (São Paulo)

.

2018

;

97

(

1

):

81

–

97

.

0034-8554

https://doi.org/10.31128/AJGP-01-18-4462

78.

Brotherton

JM

.

Human papillomavirus vaccination update: nonavalent vaccine and the two-dose schedule

.

Aust J Gen Pract

.

2018

Jul

;

47

(

7

):

417

–

21

.

[PubMed]

2208-7958